Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
45.60
+0.15 (0.33%)
Jun 6, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Biopharmaceutical
5.96B
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Growth
59.47%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
China
5.32B
Log In
Log In
Log In
Log In
Upgrade
China Growth
60.92%
Log In
Log In
Log In
Log In
Upgrade
North America
347.84M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
106.21%
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific (excluding China)
214.36M
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific (excluding China) Growth
3.00%
Log In
Log In
Log In
Log In
Upgrade
Europe
62.29M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
6.83%
Log In
Log In
Log In
Log In
Upgrade
South America
21.15M
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Overseas
-
Log In
Log In
Log In
Log In
Upgrade